Idera Pharmaceuticals reported $-7557000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2545M 1153M
Aceto ACET:US -10827000 10.53M
Agenus AGEN:US $ -66.4M 25.02M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Biogen BIIB:US $ 794M 308.3M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Cytrx CYTR:US -1181210 98.64K
Dynavax Technologies DVAX:US $ 3.94M 24.59M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
Idera Pharmaceuticals IDRA:US $ -7.56M 2.47M
Merk MRK:US $ 1497M 1517M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Pfizer PFE:US $ 5914M 397M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Seattle Genetics SGEN:US $ -89.6M 32.82M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
X T L Biopharmaceuticals XTLB:US -257000 40K